Activation-induced markers detect vaccine-specific CD4⁺ T cell responses not measured by assays conventionally used in clinical trials by Bowyer, G, Rampling, T, Powlson, J, Morter, R, Wright, D, Hill, A, Ewer, K

Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus by Powlson, J, Wright, D, Zeltina, A, Giza, M, Nielsen, M, Rampling, T, Venkatraman, N, Bowden, T, Hill, A, Ewer, K

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine by Folegatti, P, Bellamy, D, Roberts, R, Powlson, J, Edwards, N, Mair, C, Bowyer, G, Poulton, I, Mitton, C, Green, N, Berrie, E, Lawrie, A, Hill, A, Ewer, K, Hermon-Taylor, J, Gilbert, S

Prime and target immunization protects against liver-stage malaria in mice by Gola, A, Silman, D, Walters, A, Uderhardt, S, Salman, A, Halbroth, B, Bellamy, D, Bowyer, G, Powlson, J, Baker, M, Venkatraman, N, Poulton, I, Berrie, E, Roberts, R, Lawrie, A, Angus, B, Khan, S, Janse, C, Ewer, K, Germain, R, Spencer, A, Hill, A

High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant by Venkatraman, N, Bowyer, G, Edwards, NJ, Griffiths, O, Powlson, J, Silman, D, Morter, R, Folegatti, PM, Minassian, AM, Poulton, ID, Collins, K, Brod, F, Angell-Manning, P, Berrie, E, Brendish, N, Glenn, G, Fries, L, Baum, J, Blagborough, AM, Roberts, R, Lawrie, AM, Lewis, DJ, Faust, SN, Gilbert, S, Ewer, KJ, Hill, AV

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal by Venkatraman, N, Ndiaye, B, Bowyer, G, Wade, D, Sridhar, S, Wright, D, Powlson, J, Ndiaye, I, Dièye, S, Thompson, C, Bakhoum, M, Morter, R, Capone, S, Del Sorbo, M, Jamieson, S, Rampling, T, Dattoo, M, Roberts, R, Poulton, I, Griffiths, O, Ballou, W, Roman, F, Lewis, DJM, Lawrie, A, Imoukhuede, E, Gilbert, S, Dieye, TN, Ewer, KJ, Hill, A, Mboup, S

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP by Rampling, T, Ewer, KJ, Bowyer, G, Edwards, N, Wright, D, Sridhar, S, Payne, R, Powlson, J, Bliss, C, Venkatraman, N, Poulton, I, de Graaf, H, Gbesemete, D, Grobbelaar, A, Davis, H, Roberts, R, Angus, B, Ivinson, K, Weltzin, R, Rajkumar, B-Y, Wille-Reece, U, Lee, C, Ockenhouse, C, Sinden, R, Gerry, S, Lawrie, A, Vekemans, J, Morelle, D, Lievens, M, Ballou, RW, Lewis, DJM, Cooke, GS, Faust, SN, Gilbert, S, Hill, A

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA by Ewer (nee Russell), K, Rampling, T, Venkatraman, N, Bowyer, G, Wright, D, Lambe, T, Imoukhuede, E, Payne, R, Fehling, S, Strecker, T, Biedenkopf, N, Krähling, V, Tully, C, Edwards, N, Bentley, E, Samuel, D, Labbe, G, Jin, J, Gibani, M, Minhinnick, A, Wilkie, M, Poulton, I, Lella, N, Roberts, R, Hartnell, F, Bliss, C, Sierra-Davidson, K, Powlson, J, Berrie, E, Tedder, R, Roman, F, Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Mbaya, O, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Wright, E, Becker, S, Graham, B, Koup, R, Levine, M, Volkmann, A, Chaplin, P, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A